Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 141
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 50
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases
Ying Liu, Wei Ding, Jianxun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114993-114993
Open Access | Times Cited: 50
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Translational Oncology (2023) Vol. 39, pp. 101821-101821
Open Access | Times Cited: 44
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
Osteomyelitis and non-coding RNAS: A new dimension in disease understanding
Md Sadique Hussain, Nusrat K. Shaikh, Mohit Agrawal, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155186-155186
Closed Access | Times Cited: 18
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 14
Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155303-155303
Closed Access | Times Cited: 13
The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells
Yuan Zhang, Wanpeng Yu, Mengmeng Chen, et al.
Nanoscale (2023) Vol. 15, Iss. 29, pp. 12137-12156
Closed Access | Times Cited: 33
Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role
Sandra Kannampuzha, Abilash Valsala Gopalakrishnan
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 22
Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer
Roxana Damiescu, Thomas Efferth, Mona Dawood
Cancer Letters (2024) Vol. 584, pp. 216623-216623
Open Access | Times Cited: 11
The regulatory mechanisms of oncomiRs in cancer
Khalid Otmani, Rédouane Rouas, Mimoune Berehab, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116165-116165
Open Access | Times Cited: 10
Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay
Ahmed S. Doghish, Abdullah Radwan, Mohamed Bakr Zaki, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130426-130426
Closed Access | Times Cited: 8
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
CircUGGT2 downregulation by METTL14-dependent m6A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186–3p/MAP3K9 axis
Xiaoyu Chen, Yanling Yang, Yi Yu, et al.
Pharmacological Research (2024) Vol. 204, pp. 107206-107206
Open Access | Times Cited: 8
Programmed cell death in tumor immunity: mechanistic insights and clinical implications
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
The role of lncRNA NEAT1 in human cancer chemoresistance
Feng Long, Xue Li, Jingyu Pan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications
Zhongyu Wang, Zeng-Jin Wen, Hai-Ming Xu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 35
CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis
Lei Zhang, Yuan Zhang, Xin Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei‐ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 17
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 6
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
Role of non-coding RNAs and exosomal non-coding RNAs in vasculitis: A narrative review
Xiuming Tang, Jiajuan Guo, Qi Feng, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129658-129658
Closed Access | Times Cited: 5
The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways
Alireza Mafi, Neda Hedayati, Samaneh Kahkesh, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1178-1189
Open Access | Times Cited: 5
MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Page 1 - Next Page

Scroll to top